Search results for "Diosmin"

showing 3 items of 3 documents

Agenesis of the renal segment of inferior vena cava associated with venous stasis.

2010

Congenital anomalies of the inferior vena cava is an extremely rare vascular anomaly with controversial pathogenesis. Anomalies of the inferior vena cava (IVC) are present in 0.3% to 0.5% of otherwise healthy individual and in 0.6% to 2% of patients with other cardiovascular defects. The phenomenon of absence of the IVC has been described in a variety of ways such as absence, agenesis, anomalous, and interruption of a particular segment ([infra] hepatic, pre-renal, renal, or infrarenal) of the IVC. We describe a 42-year-old man with chronic venous insufficiency, without DVT, caused by congenital absence of renal segment of the IVC

AdultMaleSettore MED/09 - Medicina InternaCardiovascular AgentsVena Cava InferiorPhlebographySettore MED/11 - Malattie Dell'Apparato CardiovascolareCombined Modality TherapyExercise TherapyVenous InsufficiencyChronic DiseaseDiosminHumansAGENESIS OF THE RENAL SEGMENT OF INFERIOR VENA CAVA ASSOCIATED WITH VENOUS STASIS.Ultrasonography Doppler ColorTomography X-Ray ComputedStockings CompressionInternational angiology : a journal of the International Union of Angiology
researchProduct

Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-…

2020

Since the end of 2019, the coronavirus SARS-CoV-2 has caused more than 1000000 deaths all over the world and still lacks a medical treatment despite the attention of the whole scientific community. Human angiotensin-converting enzyme 2 (ACE2) was recently recognized as the transmembrane protein that serves as the point of entry of SARS-CoV-2 into cells, thus constituting the first biomolecular event leading to COVID-19 disease. Here, by means of a state-of-the-art computational approach, we propose a rational evaluation of the molecular mechanisms behind the formation of the protein complex. Moreover, the free energy of binding between ACE2 and the active receptor binding domain of the SARS…

LetterPneumonia ViralProtein domainThermodynamicsPlasma protein bindingMolecular Dynamics SimulationPeptidyl-Dipeptidase ALigandsmedicine.disease_causeProtein-Protein Binding01 natural sciencesDockingBetacoronavirus03 medical and health sciencesProtein Domains0103 physical sciencesmedicineHumansGeneral Materials SciencePhysical and Theoretical ChemistryBinding siteReceptorPandemics030304 developmental biologyCoronaviruschemistry.chemical_classification0303 health sciencesBinding Sites010304 chemical physicsSARS-CoV-2Spike ProteinCOVID-19PlicamycinTransmembrane proteinEnzymechemistrySettore CHIM/03 - Chimica Generale E InorganicaMolecular Dynamics SimulationsSpike Glycoprotein CoronavirusAngiotensin-converting enzyme 2DiosminThermodynamicsAngiotensin-Converting Enzyme 2Coronavirus InfectionsProtein Binding
researchProduct

Modeling anti-allergic natural compounds by molecular topology.

2013

Molecular topology has been applied to the search of QSAR models able to identify the anti-allergic activity of a wide group of heterogeneous compounds. Through the linear discriminant analysis and artificial neural networks, correct classification percentages above 85% for both the training set and the test set have been obtained. After carrying out a virtual screening with a natural product library, about thirty compounds with theoretical anti-allergic activity have been selected. Among them, hesperidin, naringin, salinomycin, sorbitol, curcumol, myricitrin, diosmin and kinetin stand out. Some of these compounds have already been referenced as having anti-allergic activity.

Virtual screeningQuantitative structure–activity relationshipStereochemistryOrganic ChemistryDiosminDiscriminant AnalysisQuantitative Structure-Activity RelationshipGeneral MedicineComputational biologyLinear discriminant analysisModels BiologicalComputer Science Applicationschemistry.chemical_compoundHesperidinchemistryArtificial IntelligenceTest setDrug DiscoveryAnti-Allergic AgentsmedicineHumansNeural Networks ComputerMyricitrinNaringinmedicine.drugCombinatorial chemistryhigh throughput screening
researchProduct